vs
NEXTNRG, INC.（NXXT）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是NEXTNRG, INC.的1.5倍（$35.5M vs $23.0M），NEXTNRG, INC.净利率更高（-116.1% vs -304.2%，领先188.1%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 238.9%），过去两年NEXTNRG, INC.的营收复合增速更高（86.8% vs 60.5%）
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
NXXT vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.5倍
$23.0M
营收增速更快
RXRX
高出442.8%
238.9%
净利率更高
NXXT
高出188.1%
-304.2%
两年增速更快
NXXT
近两年复合增速
60.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $23.0M | $35.5M |
| 净利润 | $-26.7M | $-108.1M |
| 毛利率 | 10.3% | 59.8% |
| 营业利润率 | -107.2% | -304.8% |
| 净利率 | -116.1% | -304.2% |
| 营收同比 | 238.9% | 681.7% |
| 净利润同比 | -974.9% | 39.6% |
| 每股收益（稀释后） | $1.30 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NXXTRXRX
| Q4 25 | $23.0M | $35.5M | ||
| Q3 25 | $22.9M | $5.2M | ||
| Q2 25 | $19.7M | $19.2M | ||
| Q1 25 | $16.3M | $14.7M | ||
| Q4 24 | $6.8M | $4.5M | ||
| Q3 24 | $7.0M | $26.1M | ||
| Q2 24 | $7.4M | $14.4M | ||
| Q1 24 | $6.6M | $13.8M |
净利润NXXTRXRX
| Q4 25 | $-26.7M | $-108.1M | ||
| Q3 25 | $-14.1M | $-162.3M | ||
| Q2 25 | $-36.1M | $-171.9M | ||
| Q1 25 | $-8.8M | $-202.5M | ||
| Q4 24 | $-2.5M | $-178.9M | ||
| Q3 24 | $-10.6M | $-95.8M | ||
| Q2 24 | $-5.6M | $-97.5M | ||
| Q1 24 | $-2.7M | $-91.4M |
毛利率NXXTRXRX
| Q4 25 | 10.3% | 59.8% | ||
| Q3 25 | 10.7% | -183.8% | ||
| Q2 25 | 8.0% | -4.9% | ||
| Q1 25 | 3.2% | -48.0% | ||
| Q4 24 | 2.5% | -181.4% | ||
| Q3 24 | 8.7% | 53.7% | ||
| Q2 24 | 7.4% | 36.2% | ||
| Q1 24 | 7.0% | 19.1% |
营业利润率NXXTRXRX
| Q4 25 | -107.2% | -304.8% | ||
| Q3 25 | -39.4% | -3327.6% | ||
| Q2 25 | -156.2% | -916.8% | ||
| Q1 25 | -35.4% | -1297.9% | ||
| Q4 24 | -62.8% | -4042.4% | ||
| Q3 24 | -42.7% | -377.1% | ||
| Q2 24 | -35.2% | -697.4% | ||
| Q1 24 | -28.2% | -698.4% |
净利率NXXTRXRX
| Q4 25 | -116.1% | -304.2% | ||
| Q3 25 | -61.8% | -3135.3% | ||
| Q2 25 | -183.3% | -894.2% | ||
| Q1 25 | -54.0% | -1373.3% | ||
| Q4 24 | -36.6% | -3935.5% | ||
| Q3 24 | -152.0% | -367.5% | ||
| Q2 24 | -76.0% | -676.6% | ||
| Q1 24 | -40.6% | -662.4% |
每股收益（稀释后）NXXTRXRX
| Q4 25 | $1.30 | $-0.17 | ||
| Q3 25 | $-0.12 | $-0.36 | ||
| Q2 25 | $-0.30 | $-0.41 | ||
| Q1 25 | $-1.60 | $-0.50 | ||
| Q4 24 | $-3.72 | $-0.56 | ||
| Q3 24 | $-0.71 | $-0.34 | ||
| Q2 24 | $-0.06 | $-0.40 | ||
| Q1 24 | $-1.48 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $-19.7M | $1.1B |
| 总资产 | $11.1M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资NXXTRXRX
| Q4 25 | — | $743.3M | ||
| Q3 25 | — | $659.8M | ||
| Q2 25 | — | $525.1M | ||
| Q1 25 | — | $500.5M | ||
| Q4 24 | — | $594.4M | ||
| Q3 24 | — | $427.6M | ||
| Q2 24 | $306.8K | $474.3M | ||
| Q1 24 | $48.6K | $296.3M |
总债务NXXTRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | $9.2M | $19.0M | ||
| Q3 24 | $725.3K | $20.5M | ||
| Q2 24 | $8.8M | $22.9M | ||
| Q1 24 | $7.3M | — |
股东权益NXXTRXRX
| Q4 25 | $-19.7M | $1.1B | ||
| Q3 25 | $-16.3M | $1.0B | ||
| Q2 25 | $-13.6M | $919.1M | ||
| Q1 25 | $-5.6M | $933.9M | ||
| Q4 24 | $-12.7M | $1.0B | ||
| Q3 24 | $3.6M | $524.6M | ||
| Q2 24 | $-4.8M | $584.4M | ||
| Q1 24 | $-3.3M | $401.2M |
总资产NXXTRXRX
| Q4 25 | $11.1M | $1.5B | ||
| Q3 25 | $19.6M | $1.4B | ||
| Q2 25 | $25.5M | $1.3B | ||
| Q1 25 | $26.0M | $1.3B | ||
| Q4 24 | $22.4M | $1.4B | ||
| Q3 24 | $5.6M | $726.5M | ||
| Q2 24 | $22.4M | $775.9M | ||
| Q1 24 | $5.8M | $557.8M |
负债/权益比NXXTRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | 0.20× | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-392.6K | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-47.3M |
| 自由现金流率自由现金流/营收 | — | -133.1% |
| 资本支出强度资本支出/营收 | — | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势，按日历期对齐
经营现金流NXXTRXRX
| Q4 25 | $-392.6K | $-46.1M | ||
| Q3 25 | $-7.8M | $-117.4M | ||
| Q2 25 | $-564.5K | $-76.4M | ||
| Q1 25 | $-5.8M | $-132.0M | ||
| Q4 24 | $-1.6M | $-115.4M | ||
| Q3 24 | $3.6M | $-59.2M | ||
| Q2 24 | $-7.0M | $-82.2M | ||
| Q1 24 | $-1.4M | $-102.3M |
自由现金流NXXTRXRX
| Q4 25 | — | $-47.3M | ||
| Q3 25 | — | $-117.6M | ||
| Q2 25 | — | $-79.6M | ||
| Q1 25 | — | $-133.8M | ||
| Q4 24 | — | $-116.7M | ||
| Q3 24 | — | $-63.8M | ||
| Q2 24 | — | $-83.4M | ||
| Q1 24 | — | $-109.0M |
自由现金流率NXXTRXRX
| Q4 25 | — | -133.1% | ||
| Q3 25 | — | -2272.5% | ||
| Q2 25 | — | -413.9% | ||
| Q1 25 | — | -907.4% | ||
| Q4 24 | — | -2567.7% | ||
| Q3 24 | — | -244.6% | ||
| Q2 24 | — | -578.5% | ||
| Q1 24 | — | -789.9% |
资本支出强度NXXTRXRX
| Q4 25 | — | 3.5% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | 28.6% | ||
| Q3 24 | — | 17.5% | ||
| Q2 24 | — | 8.2% | ||
| Q1 24 | — | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
